We previously reported the identification of a subset of patients with advanced melanoma who developed hepatitis after Ipi-Nivo therapy, which was reliably predicted by cytomegalovirus (CMV) associated expansion of CD4+ effector memory T cells (TEM) cells prior to immunotherapy35. The gene discussed is CD4; the disease is hepatitis A virus infection.